Dr Susan Wyllie
Biological Chemistry and Drug Discovery, School of Life Sciences
Dr Susan Wyllie has more than 15 years of experience studying kinetoplastid biology. Specifically, her research has focused on determining the mechanisms of action and mechanisms of resistance of drugs targeting kinetoplastid parasites. Her contributions to the research of the Wellcome Centre for Anti-Infectives Research will include:
- Using complementary methodologies in the fields of genomics, chemical proteomics and cell biology to determine the modes of action and specific molecular targets of phenotypically-active compounds
- Developing new genetic and cell biology tools for the study of drug mechanism of action
- Functional characterisation of novel targets
- Developing novel cell-based assays to exploit high value drug targets
A team from the Wellcome Centre for Anti-Infectives Research (WCAIR) at the University of Dundee has developed a new parasite gene-editing technology.
Dr Susan Wyllie, Head of the Mode of Action group within WCAIR and Principal Investigator in the School of Life Sciences, underwent a successful tenure review recently.
Ingo Hein, Jens Januschke, Steve Land, Beatriz Baragana, Sheriar Hormuzdi and Susan Wyllie promoted as part of the 2020 Annual Review process for academic staff.